Tricyclic spiropiperidines or spiropyrrolidines

Details Tricyclic spiropiperidines or spiropyrrolidines Tricyclic spiropiperidines or spiropyrrolidines

2003-07-07

2008-11-11

Aulakh, Charanjit S (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S017000, C548S409000, C544S124000, C514S232800, C514S409000

Reexamination Certificate

active

07449475

ABSTRACT:
The invention provides compounds of formula (I)wherein m R1, n, R2, q, X, Y, Z, R3, R4, R5, R6, R7, R8, t, and R9are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

REFERENCES:
patent: 4010201 (1977-03-01), Lednicer
patent: 4263317 (1981-04-01), Martin et al.
patent: 5962462 (1999-10-01), Mills et al.
patent: 2006/0252751 (2006-11-01), Xue et al.
patent: 2007/0021498 (2007-01-01), Hossain
patent: 2007/0203229 (2007-08-01), Hossain
patent: 2007/0203230 (2007-08-01), Hossain
patent: 0 004 951 (1979-10-01), None
patent: 0 004 952 (1979-10-01), None
patent: 0417631 (1991-03-01), None
patent: 0 722 941 (1996-07-01), None
patent: 1061076 (2000-12-01), None
patent: WO 92/10096 (1992-06-01), None
patent: WO 96/36625 (1996-11-01), None
patent: WO 98/25605 (1998-06-01), None
patent: WO 98/31364 (1998-07-01), None
patent: WO 00/14086 (2000-03-01), None
patent: WO 01/30780 (2001-05-01), None
patent: WO 01/64213 (2001-09-01), None
patent: WO 01/98273 (2001-12-01), None
patent: WO 02/102387 (2002-12-01), None
patent: WO03/037271 (2003-05-01), None
patent: WO 2004/005295 (2004-01-01), None
patent: WO 2004/041279 (2004-05-01), None
patent: WO 2005/037814 (2005-04-01), None
patent: WO 2005/040167 (2005-05-01), None
patent: WO 2005/049620 (2005-06-01), None
patent: WO 2005/054249 (2005-06-01), None
patent: WO 2005/061499 (2005-07-01), None
patent: WO 2005/092895 (2005-10-01), None
Pujol et al., “Novel tricyclic spiropiperidines. Synthesis and adrenergic activity of spiro[1,3-benzodioxolopiperidines] and spiro[1,3-benzodioxanepiperidines]”,Eur J Med Chem31:889-894 (1996).
Mehrotra et al., “Spirocyclic Nonpeptide Glycoprotein IIb-IIIa Antagonists. Part 3: Synthesis and SAR of Potent and Specific 2,8-Diazaspiro[4.5]decanes”, Bioorganic & Medicinal Chemistry Letters 12:1103-1107 (2002).
Chen et al., “Heterodimerization and cross-desensitization between the μ-opioid receptor and the chemokine CCR5 receptor”,Eur. J. Pharmacol. 483:175-186 (2004).
Dorwald F.Z.Side Reactions in Organic Synthesis. Wiley: VCH, Weinheim, 2005. p. IX of Preface.
Godessart N., “Chemokine Receptors: Attractive Targets for Drug Discovery”,Ann. N.Y. Acad. Sci. 1051:647-657 (2005).
Knochel et al., “Highly Functionalized Organomagnesium Reagents Prepared through Haolgen-Metal Exchange”,Angew. Chem. Intl. Ed. 42:4302-4320 (2003).
Li J.J. “Grignard reaction.” in:Name Reactions: A Collection of Detailed Reaction MechanismsThird Expanded Edition Springer 2006, pp. 271-272.
Brown et al., “Novel CCR1 antagonists with improved metabolic stability”,Bioorg. Med. Chem. Lett. 14:2175-2179 (2004).
Martin et al., “Do Structurally Similar Molecules Have Similar Biological Activity?”,J. Med. Chem. 45:4350-4358 (2002).
Pozharskii et al.,Heterocycles in Life and Society. Wiley, 1997, pp. 1-6.
Thoma et al., “Orally Bioavailable Competitive CCR5 Antagonists”,J. Med. Chem. 47:1939-1955 (2004).
Thomson et al.,The Cytokine Handbook, 4thed. New York, Academic Press, 2003, pp. 1084-1087.
Ting et al., “The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: Antagonists versus agonists”,Bioorg. Med. Chem. Lett.15:3020-3023 (2005).
Xie et al., “Identification of novel series of human CCR1 antagonists”,Bioorg. Med. Chem. Lett. 18:2215-2221 (2008).

Affiliated with

Also associated with

Rating

Tricyclic spiropiperidines or spiropyrrolidines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tricyclic spiropiperidines or spiropyrrolidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic spiropiperidines or spiropyrrolidines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4036587